Alzheimer’s Disease (AD)
We are conducting a clinical trial to explore new possible treatment options for Alzheimer’s disease (AD).
To pre-qualify for this study, participants must:
Be 55–90 years old with mild to severe Alzheimer’s disease and agitation lasting at least 2 weeks
Have a confirmed diagnosis of Alzheimer’s disease by a physician or standard diagnostic methods.
Have a caregiver who spends about 10 hours per week with the participant and is willing to:
Attend all study visits and report on your condition
Ensure you follow study medication and procedures
Participate in assessments and provide consent
Have lived in a stable living environment for at least 6 weeks